Showing results (151-160 of 752) with videos related to
Sort By:
Pageof 76
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 11, 2023
Molecular Profiling in Neuro-Oncology: Where We Are, Where We're Heading, and How We Ensure Everyone Can Come AlongAlyx B Porter, Patrick Y Wen, Mei-Yin C PolleyNeuro-Oncology|November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumabMichael Prados, Timothy Cloughesy, Meghna Samant, et al.Neuro-Oncology|June 26, 2021
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumorsTobias Walbert, Rebecca A Harrison, David Schiff, et al.Endocrine|November 29, 2005
Pituitary carcinoma: diagnosis and treatmentM Beatriz S Lopes, Bernd W Scheithauer, David SchiffNeurosurgical Focus|December 1, 2006
Rare pathological variants and presentations of primary central nervous system lymphomasArnaldo Neves Da Silva, Maria Beatriz Lopes, David SchiffCancer|January 7, 2010
Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group ReportRobert Cavaliere, Gina Petroni, Maria B Lopes, et al.CNS Oncology|October 17, 2017
Regression of an intramedullary spinal cord metastasis with a checkpoint inhibitor: a case reportKester A Phillips, Elizabeth Gaughan, Alejandro Gru, et al.Surgical Neurology|September 11, 2007
Bone health in patients with brain tumorsArnaldo Neves Da Silva, Ailleen Heras-Herzig, David SchiffHematology/Oncology Clinics of North America|October 5, 2021
Central Nervous System Complications Among Oncology PatientsSebastian F Winter, Jasmin Jo, David Schiff, et al.Neuro-Oncology Practice|December 14, 2019
Checkpoint inhibitor failure in hypermutated and mismatch repair-mutated recurrent high-grade gliomasHaroon Ahmad, Camilo E Fadul, David Schiff, et al.Pageof 76